Relationship between tea consumption and pancreatic cancer risk: A meta-analysis based on prospective cohort studies and case-control studies

European Journal of Cancer Prevention

Volumn 23, Issue 5, 2014, Pages 353-360

  Chen, Ke ^a   Zhang, Qi ^a   Peng, Min ^a   Shen, Yanping ^a   Wan, Peng ^a   Xie, Guoming ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

meta analysis; pancreatic cancer; tea

Indexed keywords

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; DIETARY INTAKE; EFFECT SIZE; HUMAN; PANCREAS CANCER; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; SYSTEMATIC REVIEW; TEA; ADVERSE EFFECTS; COMPARATIVE STUDY; META ANALYSIS; PANCREATIC NEOPLASMS; PROGNOSIS; RISK FACTOR;

TEA;

CASE-CONTROL STUDIES; HUMANS; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TEA;

EID: 84905388330     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000033     Document Type: Article

References (51)

1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
2. Bhoo-Pathy N, Uiterwaal CS, Dik VK, Jeurnink SM, Bech BH, Overvad K, et al. (2013). Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol 11:1486-1492.
3. Cabrera C, Artacho R, Giménez R (2006). Beneficial effects of green tea - a review. J Am Coll Nutr 25:79-99.
4. Coughlin S, Calle E, Patel A, Thun M (2000). Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11:915-923.
5. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
6. Everhart J, Wright D (1995). Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273:1605-1609.
7. Goldbohm RA, Hertog MG, Brants HA, van Poppel G, van den Brandt PA (1996). Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88:93-100.
8. Harnack LJ, Anderson KE, Zheng W, Folsom AR, Sellers TA, Kushi LH (1997). Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: The Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 6:1081-1086.
9. Heilbrun L, Nomura A, Stemmermann G (1986). Black tea consumption and cancer risk: a prospective study. Br J Cancer 54:677-683.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560.
11. Hou I-C, Amarnani S, Chong MT, Bishayee A (2013). Green tea and the risk of gastric cancer: epidemiological evidence. World J Gastroenterol 19:3713-3722.
12. Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M (2013). Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PloS One 8:e54318.
13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009). Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
14. Ji BT, Chow WH, Hsing AW, McLaughlin JK, Dai Q, Gao YT, et al. (1997). Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 70:255-258.
15. Khan MM, Goto R, Kobayashi K, Suzumura S, Nagata Y, Sonoda T, et al. (2004). Dietary habits and cancer mortality among middle aged and older Japanese living in Hokkaido, Japan by cancer site and sex. Asian Pacific J Cancer Prev 5:58-65.
16. Khan N, Mukhtar H (2010). Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev 29:435-445.
17. Kim J, Zhang X, Rieger-Christ KM, Summerhayes IC, Wazer DE, Paulson KE, et al. (2006). Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells: requirement of the transcriptional repressor HBP1. J Biol Chem 281:10865-10875.
18. Lambert JD, Hong J, Yang GY, Liao J, Yang CS (2005). Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81:284S-291S.
19. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1992). Tea consumption and cancer risk. Nutr Cancer 17:27-31.
20. Lee AH, Su D, Pasalich M, Binns CW (2013). Tea consumption reduces ovarian cancer risk. Cancer Epidemiol 37:54-59.
21. Liang YC, Lin-Shiau SY, Chen CF, Lin JK (1999). Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin- 3-gallate. J Cell Biochem 75:1-12.
22. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Kurosawa M, et al. (2008). Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 37:25-30.
23. Luo J, Inoue M, Iwasaki M, Sasazuki S, Otani T, Ye W, et al. (2007). Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 16:542-548.
24. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS (2001). Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286:921-929.
25. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK (2004). EGCG downregulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24:703-710.
26. Mizuno S, Watanabe S, Nakamura K, Omata M, Oguchi H, Ohashi K, et al. (1992). A multi-institute case-control study on the risk factors of developing pancreatic cancer. Jpn J Clin Oncol 22:286-291.
27. Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, Reber HA, et al. (2002). Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer 98:761-769.
28. Nagano J, Kono S, Preston DL, Mabuchi K (2001). A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). CCC 12:501-508.
29. Nakamura K, Nagata C, Wada K, Tamai Y, Tsuji M, Takatsuka N, et al. (2011). Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: a prospective cohort study in Japan. Jpn J Clin Oncol 41:225-231.
30. Nechuta S, Shu XO, Li HL, Yang G, Ji BT, Xiang YB, et al. (2012). Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr 96:1056-1063.
31. Ng TP, Feng L, Niti M, Kua EH, Yap KB (2008). Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 88:224-231.
32. Qian Y, Zhu K, Wang Q, Li G, Zhao X (2013). Antimutagenic activity and preventive effect of black tea on buccal mucosa cancer. Oncol Lett 6:595-599.
33. Sartippour MR, Shao Z-M, Heber D, Beatty P, Zhang L, Liu C, et al. (2002). Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132:2307-2311.
34. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2007). EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13:440-452.
35. Shibata A, Mack TM, Paganini-Hill A, Ross RK, Henderson BE (1994). A prospective study of pancreatic cancer in the elderly. Int J Cancer 58:46-49.
36. Sun C-L, Yuan J-M, Koh W-P, Mimi CY (2006). Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27:1310-1315.
37. IARC Working Group on the Evaluation Of Carcinogenic Risks to Humans (2004). Tobacco smoke and involuntary smoking. World Health Organization/International Agency for Research on Cancer. IARC Monogr Eval Carcinog Risks Hum 83:1-1438.
38. Turati F, Galeone C, Talamini R, Franceschi S, Manzari M, Gallino G, et al. (2011). Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: a pooledanalysis of two Italian case-control studies. Eur J Cancer Prev 20:287-292.
39. Wang J, Zhang W, Sun L, Yu H, Ni QX, Risch HA, et al. (2012). Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol 36:e354-e358.
40. Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, et al. (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
41. Woo HD, Kim J (2013). Dietary flavonoid intake and risk of stomach and colorectal cancer. World J Gastroenterol 19:1011-1019.
42. Yamakawa S, Asai T, Uchida T, Matsukawa M, Akizawa T, Oku N (2004). (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 210:47-55.
43. Yang CS, Chung JY, Yang G-y, Chhabra SK, Lee M-J (2000). Tea and tea polyphenols in cancer prevention. J Nutr 130:472S-478S.
44. Yang CS, Wang X, Lu G, Picinich SC (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429-439.
45. Yang CS, Wang H (2011). Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res 55:819-831.
46. Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, et al. (2007). Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 16:1219-1223.
47. Yong Feng W(2006). Metabolism of green tea catechins: an overview. Curr Drug Metab 7:755-809.
48. Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH (1995). Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control 6:532-538.
49. Yuan JM (2013). Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr 98:1676s-1681s.
50. Zhang M, Binns CW, Lee AH (2002). Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 11:713-718.
51. Zheng W, McLaughlin J, Gridley G, Bjelke E, Schuman L, Silverman D, et al. (1993). A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 4:477-482.